MetLife Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-23,409
| Closed | -$178K | – | 2918 |
|
|
2022
Q1 | $178K | Buy |
23,409
+8,450
| +56% | +$64.2K | ﹤0.01% | 2420 |
|
|
2021
Q4 | $153K | Buy |
14,959
+5,019
| +50% | +$51.2K | ﹤0.01% | 2217 |
|
|
2021
Q3 | $133K | Sell |
9,940
-5,754
| -37% | -$77.2K | ﹤0.01% | 2306 |
|
|
2021
Q2 | $344K | Hold |
15,694
| – | – | ﹤0.01% | 1797 |
|
|
2021
Q1 | $378K | Hold |
15,694
| – | – | ﹤0.01% | 1684 |
|
|
2020
Q4 | $282K | Hold |
15,694
| – | – | ﹤0.01% | 1798 |
|
|
2020
Q3 | $181K | Hold |
15,694
| – | – | ﹤0.01% | 1914 |
|
|
2020
Q2 | $381K | Hold |
15,694
| – | – | ﹤0.01% | 1526 |
|
|
2020
Q1 | $173K | Hold |
15,694
| – | – | ﹤0.01% | 1781 |
|
|
2019
Q4 | $415K | Hold |
15,694
| – | – | ﹤0.01% | 1562 |
|
|
2019
Q3 | $358K | Hold |
15,694
| – | – | ﹤0.01% | 1597 |
|
|
2019
Q2 | $481K | Buy |
15,694
+6,039
| +63% | +$185K | 0.01% | 1502 |
|
|
2019
Q1 | $160K | Hold |
9,655
| – | – | ﹤0.01% | 2095 |
|
|
2018
Q4 | $185K | Hold |
9,655
| – | – | ﹤0.01% | 1955 |
|
|
2018
Q3 | $505K | Hold |
9,655
| – | – | 0.01% | 1543 |
|
|
2018
Q2 | $420K | Buy |
9,655
+3,123
| +48% | +$136K | 0.01% | 1512 |
|
|
2018
Q1 | $242K | Buy |
+6,532
| New | +$242K | ﹤0.01% | 1786 |
|